Business Daily from THE HINDU group of publications
Friday, Mar 02, 2007
ePaper
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Regulatory Bodies & Rulings
Finnish nod for Aurobindo unit

Our Bureau

Hyderabad, March 1

Aurobindo Pharma Ltd has announced that NAM (National Agency for Medicines), Finland has given the go-ahead for the manufacture of Cefuroxime injectable 750 mg and 1,500 mg at its Unit-VI facility in Chitkul village of Medak district.

The Finnish authorities were satisfied with the manufacturing practices at the site and stated that it fulfils the prescribed EU-GMP standards, according to a company press release.

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Skoda announces price cut; Hyundai plans to raise prices

Dividend distribution tax: It's better off being foreign branch office
US co to develop, sell Ranbaxy's statin
Himatsingka buys 70% stake in Italian co
Kuwait group to set up 5-star hotel in Kochi
Finnish nod for Aurobindo unit
Tie-up for new gas pipeline project
No change in RIL's petro prices
Oil India IPO likely by Oct
Oil marketing firms losing Rs 100 cr a day
Tata Motor's UV range posts highest sales in February
Hero Honda sales up 11.8% in Feb
M&M Feb sales up 19.2%

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line